Physician profile
Robert Goldberg
NPI 1154408177
$1,584.02
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $61.99 · 2021: $247 · 2022: $844 · 2023: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $533.77 | 2019-2023 | |
| Exeltis, USA INC. | $370.38 | 2019-2023 | Slynd |
| Mayne Pharma Commercial LLC | $132.19 | 2021-2022 | |
| Myovant Sciences INC. | $95.26 | 2021-2022 | |
| Scynexis, INC. | $60.52 | 2022 | |
| Therapeuticsmd, INC. | $53.18 | 2020-2022 | |
| Medicem INC. | $47.62 | 2020-2022 | |
| Allergan, INC. | $46.85 | 2019 | |
| Tesaro, INC. | $43.89 | 2019 | |
| Organon LLC | $35.88 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $35.40 | 2021 | |
| Exact Sciences Corporation | $24.96 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $21.56 | 2022 | |
| Boston Scientific Corporation | $17.32 | 2023 | |
| Agile Therapeutics, INC. | $15.04 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.68 | 2019 | |
| Covidien LP | $12.79 | 2019 | |
| Ascend Therapeutics US, LLC | $11.61 | 2021 | |
| Aspira Women'S Health INC | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.